![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Douglas Tremblay, MD
AML Specialist
Specialities: Myelofibrosis, Myelodysplastic Syndromes, Acute Myeloid Leukemia
Spoken languages: English
Clinical Expertise
- Acute Myeloid Leukemia
- Myelofibrosis
- Myelodysplastic Syndromes
- Acute Lymphoid Leukemia
About
Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms.
Location
Mount Sinai Health System: 1470 Madison Ave #6th, New York, NY 10029, USA
Get the latest thought leadership on your Myeloproliferative Neoplasm delivered straight
By subscribing to the Healthtree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2025 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811